T. lt； P gt； present invention； oacute； n provides a single monoclonal antibody (e.g. human and human monoclonal antibodies) combined with human lymphocyte induced common action antibody, showing suitable functional characteristics in terms of treatment and amperage； eacute； utico, e.g, The ability to stimulate human activity. Tambi amp； eacute； n provides mol amp； eacute； cute； cuts de amp； Aacute； nucleico, which is used to code the antibody of the invention； oacute； N, the carrier of expui amp； oacute； N, the carrier of expui amp； oacute； N,c amp；Eacute；Lulas Hu Amp；Eacute；Sped and M Amp；Eacute；All for expression of inventory amp；Oacute；N.Tambi Amp；Eacute；N.Proteconjugados，Mol Amp；Eacute；Culas Biespec Amp；IACUTE；Pharmic and Amp；Eacute；Use；Utcas include of inventory Amp；OACE； N. the invention of antibodies； oacute； n may be used as a stimulant, for example, to stimulate or enhance a person's immune response, for example,T espc amp； Iacute； Ant amp； Iacute； gene of lymphocyte is anti-tumor or Ant amp； Iacute； gene virus response. The antibody and ampere； oacute； n tambi amp； eacute； n can be used in combination with CI amp； oacute； n can be processed together with other antibodies (e.g., antibodies of PD-1, PD-L1 and / or CTLA-4), e.g., C amp； Aacute； NCER. Therefore, antibodies can be used in therapeutic and AMP, eacute, uticas, M amp, eacute and other applications； all of these applications can be used to detect protein and AMP, Iacute, Na ICOS lt； / P gt；<；p>；LA PRESENTE INVENCIÓ；N PROPORCIONA ANTICUERPOS MONOCLONALES AISLADOS (POR EJEMPLO, ANTICUERPOS MONOCLONALES HUMANIZADOS Y HUMANOS) QUE SE UNEN AL COESTIMULADOR INDUCIBLE DE LINFOCITOS T (ICOS) HUMANO Y EXHIBEN PROPIEDADES FUNCIONALES CONVENIENTES DESDE EL PUNTO DE VISTA TERAPÉ；UTICO, POR EJEMPLO, LA CAPACIDAD DE ESTIMULAR LA ACTIVIDAD DEL ICOS HUMANO. TAMBIÉ；N SE PROPORCIONAN MOLÉ；CULAS DE Á；CIDO NUCLEICO QUE CODIFICAN LOS ANTICUERPOS DE LA INVENCIÓ；N
